Latest Articles

Open Access
Serious Immune-related Adverse Events Are Associated With Greater Efficacy of Nivolumab Therapy Against Non-small Cell Lung Cancer
JIRI BLAZEK, PETR HOSEK, KAROLINA HRABCOVA, MONIKA BRATOVA, JURAJ KULTAN, MICHAL HRNCIARIK, MARKETA CERNOVSKA, PETRA ZEMANOVA, JANA KREJCI, LEONA KOUBKOVA, MAREK STASTNY and MARTIN SVATON

In Vivo September 2023, 37 (5) 2229-2236; DOI: https://doi.org/10.21873/invivo.13324
Open Access
Effects of Chitosan on Chondrocytes Derived from Human Nasal Septal Cartilage
YU-HSUN CHIU, I-CHENG CHEN, TZU-HAN LIN, TAI-HORNG YOUNG and HSU-WEI FANG

In Vivo September 2023, 37 (5) 2001-2005; DOI: https://doi.org/10.21873/invivo.13297
Open Access
In Vitro Carbon Ion Beam and Gemcitabine Chemoradiation in a Mucoepidermoid Carcinoma Cell Line
THOMAS SCHNEIDER, FELIX ZWICKER, PETER ERNST HUBER, JÜRGEN DEBUS and HENRIK HAUSWALD

In Vivo September 2023, 37 (5) 1951-1959; DOI: https://doi.org/10.21873/invivo.13291
Open Access
Renieramycin T Derivative DH_22 Induces p53-dependent Apoptosis in Lung Cancer Cells
INDIANA GITA ANGGRAENI, ZIN ZIN EI, DAIKI HOTTA, MASASHI YOKOYA and PITHI CHANVORACHOTE

In Vivo September 2023, 37 (5) 1960-1966; DOI: https://doi.org/10.21873/invivo.13292
Open Access
Serum Albumin Affects the Time-to-treatment Failure of Alectinib: A Multicenter Retrospective Study
KENGO UMEHARA, KAORI YAMA, KEISUKE GOTO, TAKANOBU HOSHI, TOMOAKI HATAKEYAMA, MARIKO ISAJI, SHINYA TAKADA, KAYO YAMAGISHI, KOZO MINO and HIDEKI SATO

In Vivo September 2023, 37 (5) 2260-2267; DOI: https://doi.org/10.21873/invivo.13328
Open Access
Pathogenesis of Endometriosis: Focus on Adenogenesis-related Factors
PIETRO G. SIGNORILE, ALFONSO BALDI, ROSA VICECONTE, ANDREA RONCHI and MARCO MONTELLA

In Vivo September 2023, 37 (5) 1922-1930; DOI: https://doi.org/10.21873/invivo.13288
Open Access
Clinical Outcomes of Radiotherapy for Stage 1 Glottic Carcinoma: Comparing Accelerated Hyperfractionation and Once-daily Fractionation
MASASHI ENDO, YUKIKO FUKUDA, KOHEI OKADA, KAZUNARI OGAWA, MICHIKO NAKAMURA, SATORU TAKAHASHI, ERI MURAKAMI, CHIAKI SHIBAYAMA, MASAHIRO KAWAHARA, KEIKO AKAHANE, RYUTARO ONAGA, TAKAFUMI NAGATOMO, TAKEHARU KANAZAWA, HIROSHI NISHINO, HARUSHI MORI and KATSUYUKI SHIRAI

In Vivo September 2023, 37 (5) 2320-2326; DOI: https://doi.org/10.21873/invivo.13335
Open Access
COVID-19-related Floating Thrombus in the Ascending Aorta – A Case Report
ROXANA CARMEN GEANA, REZA NAYYERANI, RAZVAN PETRU DRAGULESCU, IOANA MARINICA, NICOLAE BACALBASA, IRINA BALESCU, CAMELIA DIACONU, VLAD ANTON ILIESCU, VICTOR CAUNI and OVIDIU STIRU

In Vivo September 2023, 37 (5) 2381-2386; DOI: https://doi.org/10.21873/invivo.13343
Open Access
Pembrolizumab Monotherapy Versus Pembrolizumab Plus Chemotherapy in Patients With Head and Neck Squamous Cell Carcinoma
MIOKO MATSUO, MUNEYUKI MASUDA, MORIYASU YAMAUCHI, MASAHIKO TAURA, KAZUKI HASHIMOTO, RYUNOSUKE KOGO, RINA JIROMARU, TAKAHIRO HONGO, TOMOMI MANAKO and TAKASHI NAKAGAWA

In Vivo September 2023, 37 (5) 2188-2196; DOI: https://doi.org/10.21873/invivo.13318
Open Access
Utility of Precision Oncology Using Cancer Genomic Profiling for Head and Neck Malignancies
MIOKO MATSUO, KAZUKI HASHIMOTO, RYUNOSUKE KOGO, RINA JIROMARU, TAKAHIRO HONGO, TOMOMI MANAKO and TAKASHI NAKAGAWA

In Vivo September 2023, 37 (5) 2147-2154; DOI: https://doi.org/10.21873/invivo.13312

Main menu

User menu

Search

Latest Articles

Pages